Abrahamson D R, Caulfield J P
Lab Invest. 1985 Feb;52(2):169-81.
To determine the fate of circulating antibodies against the basement membrane glycoprotein laminin, affinity-purified sheep antilaminin IgG (S alpha L) was radioiodinated and intravenously injected into rats. Twenty-four hours later, approximately 60% of the bound S alpha L was present in the kidneys, spleen, small intestine, and liver and less than 1% was present within the lungs and heart. S alpha L bound rapidly to the glomerular basement membrane and reached maximal levels 75 minutes after injection. Fifteen days later, 65% of maximal levels remained within the glomerular basement membrane as shown by immunofluorescent photometry. Injected S alpha L, S alpha L that had been further purified against a pepsin-resistant subfragment of laminin (S alpha P1), and rabbit alpha L (Rb alpha L) bound in identical patterns with various basement membranes in both the rat and mouse as shown by immunofluorescent microscopy. In addition, injected conjugates of S alpha L and horseradish peroxidase (S alpha L-HRP), S alpha P1-HRP, and Rb alpha L-HRP had the same ultrastructural distribution in both rats and mice. In the kidneys, HRP reaction product was present throughout the full thickness of the glomerular basement membrane, on the base of the epithelial foot processes, and throughout the tubular basement membrane. In the spleen, alpha L was within basement membrane-like material at the periphery of the white pulp, in cords of the red pulp, and surrounding the venous sinuses. Intestinal alpha L was visualized throughout the subendothelial, crypt, and villous epithelial basement membranes and on the basal surface of the epithelium. In the liver, alpha L was present throughout the basement membranes of the portal and central veins and bile duct epithelium and on basement membrane-like structures in the space of Disse of hepatic sinusoids. Sheep, rabbits, and rats immunized against laminin did not develop antibasement membrane disease. Autoantibodies (IgG) were not detected in their basement membranes and rat alpha L injected into rats did not bind to the glomerular basement membrane. We conclude that the intravenous injection of heterologous alpha L results in the rapid deposition of alpha L within basement membranes of organs with fenestrated endothelia, laminin is present throughout basement membranes and on the surface of the epithelia adjoining basement membranes, and animals generally do not produce alpha L that binds to autologous or homologous basement membranes.
为了确定针对基底膜糖蛋白层粘连蛋白的循环抗体的命运,将亲和纯化的羊抗层粘连蛋白IgG(SαL)进行放射性碘化,并静脉注射到大鼠体内。24小时后,约60%结合的SαL存在于肾脏、脾脏、小肠和肝脏中,而肺和心脏中的含量不到1%。SαL迅速结合到肾小球基底膜上,并在注射后75分钟达到最高水平。15天后,通过免疫荧光光度法显示,最高水平的65%仍保留在肾小球基底膜中。如免疫荧光显微镜所示,注射的SαL、针对层粘连蛋白抗胃蛋白酶亚片段进一步纯化的SαL(SαP1)以及兔αL(RbαL)与大鼠和小鼠的各种基底膜以相同模式结合。此外,注射的SαL与辣根过氧化物酶的缀合物(SαL-HRP)、SαP1-HRP和RbαL-HRP在大鼠和小鼠中具有相同的超微结构分布。在肾脏中,HRP反应产物存在于肾小球基底膜的整个厚度、上皮足突基部以及整个肾小管基底膜上。在脾脏中,αL存在于白髓周边、红髓索以及静脉窦周围的基底膜样物质中。肠道中的αL可见于整个内皮下、隐窝和绒毛上皮基底膜以及上皮的基底表面。在肝脏中,αL存在于门静脉、中央静脉和胆管上皮的整个基底膜以及肝血窦狄氏间隙中的基底膜样结构上。用层粘连蛋白免疫的绵羊、兔子和大鼠未发生抗基底膜疾病。在它们的基底膜中未检测到自身抗体(IgG),并且注射到大鼠体内的大鼠αL未与肾小球基底膜结合。我们得出结论,静脉注射异源αL会导致αL在具有有孔内皮的器官基底膜内迅速沉积,层粘连蛋白存在于整个基底膜以及与基底膜相邻的上皮表面,并且动物通常不会产生与自身或同源基底膜结合的αL。